Detalhe da pesquisa
1.
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study.
Rheumatology (Oxford)
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092032
2.
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet's Syndrome and Psoriatic Arthritis.
Int J Mol Sci
; 24(10)2023 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240162
3.
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale.
Rheumatology (Oxford)
; 61(1): 185-194, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839741
4.
Power and spectral Doppler ultrasound in suspected active sacroiliitis: a comparison with magnetic resonance imaging as gold standard.
Rheumatology (Oxford)
; 60(3): 1338-1345, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944757
5.
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry.
Rheumatology (Oxford)
; 60(12): 5705-5712, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961014
6.
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
Clin Exp Rheumatol
; 39(1): 187-195, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452353
7.
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study.
Clin Exp Rheumatol
; 38(6): 1138-1144, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301435
8.
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.
Clin Exp Rheumatol
; 38(4): 621-625, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694738
9.
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis.
Mediators Inflamm
; 2020: 3203241, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061825
10.
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
Mediators Inflamm
; 2020: 6872402, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508524
11.
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease.
Mediators Inflamm
; 2020: 8054961, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33122969
12.
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis.
Mediators Inflamm
; 2020: 6983272, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317863
13.
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.
Mediators Inflamm
; 2020: 8294560, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410867
14.
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network.
Mediators Inflamm
; 2020: 1936960, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565720
15.
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor-Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network.
Mediators Inflamm
; 2020: 8562485, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831641
16.
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.
Clin Exp Rheumatol
; 37(4): 680-683, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943133
17.
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.
Clin Exp Rheumatol
; 37(2): 301-305, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719968
18.
Musculoskeletal manifestations in hereditary periodic fever syndromes.
Clin Exp Rheumatol
; 36 Suppl 110(1): 25-31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742055
19.
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.
Clin Exp Rheumatol
; 36 Suppl 110(1): 3-9, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742053
20.
The eye involvement in monogenic autoinflammatory diseases: literature review and update.
Clin Exp Rheumatol
; 36 Suppl 110(1): 44-53, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742057